News

Oncimmune Holdings results published from the ECLS study

The study is believed to be the largest randomised controlled trial for the detection of lung cancer using blood-based biomarkers and demonstrates a 36% reduction in later stage diagnoses of lung cancer..

News

Oncimmune Holdings results published from the ECLS study

The study is believed to be the largest randomised controlled trial for the detection of lung cancer using blood-based biomarkers and demonstrates a 36% reduction in later stage diagnoses of lung cancer..

News

FTSE 100

Funds